CESAR, Saladax begin patient enrollment in paclitaxel CEPAC-TDM trial for NSCLC - HER2 Support Group Forums

		HER2 Support Group Forums > General Cancer News
CESAR, Saladax begin patient enrollment in paclitaxel CEPAC-TDM trial for NSCLC

General Cancer News Latest Breast Cancer News from Moreover Technologies

Reply

04-27-2011, 01:45 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,104	CESAR, Saladax begin patient enrollment in paclitaxel CEPAC-TDM trial for NSCLC In collaboration with Saladax Biomedical, Inc., the Central European Society for Anticancer Drug Research announced today that enrollment has begun in the CEPAC-TDM trial of paclitaxel therapeutic drug management with subsequent pharmacokinetic-guided dose adjustment in patients being treated for advanced non-small cell lung cancer. More...

Reply

« Previous Thread | Next Thread »

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Forum Rules

All times are GMT -7. The time now is 11:39 AM.

free webpage hit counter